Anzeige
Mehr »
Donnerstag, 09.04.2026 - Börsentäglich über 12.000 News
Oregen Energy baut Position aus - während Öl bei $96 konsolidiert und Namibias Mega-Ölboom weiter eskaliert
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Investing.com

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
04:18Calfrac appoints Scarlett Crockatt as new CFO
03:42Forte Biosciences prices $150M stock offering at $26.27/share
02:06Cathie Wood's ARK sells Teradyne stock, buys more Tesla
02:06Vireo Growth completes Hawthorne Gardening acquisition
01:42ACP Holdings closes $200M SPAC IPO, lists on Nasdaq
01:30Vistra prices $4 billion senior notes offering across 4 tranches
01:18Compass Point cuts Circle Internet stock rating on margin concerns
01:18BofA cuts RPM International stock price target on raw material costs
00:54Truist Securities reiterates Hold on Costco stock, $977 target
00:54Mizuho reiterates Meta stock rating on Muse Spark AI rollout
00:54BofA reiterates Rocket Cos stock Buy rating at $19 target
00:30Jefferies reiterates FedEx stock rating on spin-off potential
00:30Evercore ISI reiterates Constellation Brands stock rating on guidance
00:18Jefferies reiterates Buy on HubSpot stock ahead of investor event
00:18Morgan Stanley initiates NovaGold stock coverage at overweight, $13.80 target
MiIngles Markets nominates two directors amid proxy fight
MiClear Street initiates REalloys stock with buy rating on rare earth potential
MiWilliam Blair reiterates Market Perform on CarMax stock amid sales improvement
MiMizuho reiterates Range Resources stock rating on steady execution
MiStifel reiterates Oruka Therapeutics stock rating ahead of trial data
MiMizuho cuts ExxonMobil stock price target on earnings headwinds
MiloanDepot partners with Figure to launch 5x5 HomeLoan product
MiDPM Metals nominates Martin Horgan to board of directors
MiAptar Digital Health partners with Enable Injections on enFuse system
MiVanda initiates trial of NEREUS for GLP-1 therapy side effects